These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 21605671)
1. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate. Fontana MC; Rezer JF; Coradini K; Leal DB; Beck RC Eur J Pharm Biopharm; 2011 Oct; 79(2):241-9. PubMed ID: 21605671 [TBL] [Abstract][Full Text] [Related]
2. Nanoencapsulation of Clobetasol Propionate Decreases Its Penetration to Skin Layers Without Changing Its Relative Skin Distribution. de Andrade DF; Fontana MC; Pohlmann AR; Guterres SS; Carlos R; Beck R J Nanosci Nanotechnol; 2015 Jan; 15(1):875-9. PubMed ID: 26328452 [TBL] [Abstract][Full Text] [Related]
3. Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory action in a model of irritant contact dermatitis in mice. Rigon C; Marchiori MCL; da Silva Jardim F; Pegoraro NS; Chaves PDS; Velho MC; Beck RCR; Ourique AF; Sari MHM; Oliveira SM; Cruz L Eur J Pharm Sci; 2019 Sep; 137():104969. PubMed ID: 31238095 [TBL] [Abstract][Full Text] [Related]
4. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Ourique AF; Melero A; de Bona da Silva C; Schaefer UF; Pohlmann AR; Guterres SS; Lehr CM; Kostka KH; Beck RC Eur J Pharm Biopharm; 2011 Sep; 79(1):95-101. PubMed ID: 21402157 [TBL] [Abstract][Full Text] [Related]
5. Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study. Marchiori ML; Lubini G; Dalla Nora G; Friedrich RB; Fontana MC; Ourique AF; Bastos MO; Rigo LA; Silva CB; Tedesco SB; Beck RC Drug Dev Ind Pharm; 2010 Aug; 36(8):962-71. PubMed ID: 20590450 [TBL] [Abstract][Full Text] [Related]
6. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects. Mathes C; Melero A; Conrad P; Vogt T; Rigo L; Selzer D; Prado WA; De Rossi C; Garrigues TM; Hansen S; Guterres SS; Pohlmann AR; Beck RCR; Lehr CM; Schaefer UF J Control Release; 2016 Feb; 223():207-214. PubMed ID: 26686081 [TBL] [Abstract][Full Text] [Related]
7. Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release, and photostability. Fontana MC; Coradini K; Pohlmann AR; Guterres SS; Beck RC J Nanosci Nanotechnol; 2010 May; 10(5):3091-9. PubMed ID: 20358904 [TBL] [Abstract][Full Text] [Related]
8. Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system. Fontana MC; Coradini K; Guterres SS; Pohlmann AR; Beck RC J Biomed Nanotechnol; 2009 Jun; 5(3):254-63. PubMed ID: 20055007 [TBL] [Abstract][Full Text] [Related]
9. Topical application of clobetasol 17-propionate from various cream bases by using Wistar rat as an animal model. Fang JY; Shen KL; Huang YB; Wu PC; Tsai YH Kaohsiung J Med Sci; 1998 May; 14(5):286-93. PubMed ID: 9619014 [TBL] [Abstract][Full Text] [Related]
10. Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model. Karami H; Niavand MR; Haddadi R; Noriyan A; Vafaei SY Int J Pharm; 2024 May; 656():124029. PubMed ID: 38527566 [TBL] [Abstract][Full Text] [Related]
11. In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery. Şenyiğit T; Sonvico F; Rossi A; Tekmen I; Santi P; Colombo P; Nicoli S; Özer Ö Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035957 [TBL] [Abstract][Full Text] [Related]
12. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial. Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513 [TBL] [Abstract][Full Text] [Related]
13. Influence of the type of vegetable oil on the drug release profile from lipid-core nanocapsules and in vivo genotoxicity study. Rigo LA; Frescura V; Fiel L; Coradini K; Ourique AF; Emanuelli T; Quatrin A; Tedesco S; Silva CB; Guterres SS; Pohlmann AR; Beck RC Pharm Dev Technol; 2014 Nov; 19(7):789-98. PubMed ID: 23978050 [TBL] [Abstract][Full Text] [Related]
14. Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization. Alves PM; Pohlmann AR; Guterres SS Pharmazie; 2005 Dec; 60(12):900-4. PubMed ID: 16398265 [TBL] [Abstract][Full Text] [Related]
15. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies. Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A Colloids Surf B Biointerfaces; 2014 Jul; 119():145-53. PubMed ID: 24767976 [TBL] [Abstract][Full Text] [Related]
16. An experimental model of contact dermatitis: evaluation of the oxidative profile of Wistar rats treated with free and nanoencapsulated clobetasol. Jaques JA; Rezer JF; Ruchel JB; Souza Vdo C; Pinheiro Kde V; Schlemmer KB; Schlemmer JB; Bertoldo TM; Martins NM; Bertoncheli Cde M; Fontana MC; Beck RC; Leal DB Redox Rep; 2012; 17(5):206-13. PubMed ID: 23068967 [TBL] [Abstract][Full Text] [Related]
17. Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System. de Andrade DF; Zuglianello C; Pohlmann AR; Guterres SS; Beck RC AAPS PharmSciTech; 2015 Dec; 16(6):1409-17. PubMed ID: 25986595 [TBL] [Abstract][Full Text] [Related]
18. Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice. Bovenschen HJ; Van de Kerkhof PC J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):439-44. PubMed ID: 19845822 [TBL] [Abstract][Full Text] [Related]
19. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies. Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A Colloids Surf B Biointerfaces; 2013 Feb; 102():86-94. PubMed ID: 23000677 [TBL] [Abstract][Full Text] [Related]
20. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream. Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]